Potential New Treatment Approach for Triple-Negative Breast Cancer | Cancer - Advances, Knowledge, Integrative & Holistic Treatments | Scoop.it

"

Scientists from Austria and Greece examined 170 tumor samples from patients with triple-negative breast cancer and found that over half of these women had high levels of the MET biomarker.

The study also showed that women with high levels of this biomarker were three times more likely to have a breast cancer recurrence within 5 years of diagnosis than those with low levels (33% vs 11%). Nearly 90% of grade 3 tumors had high levels MET expression."


Via Susan Zager